Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Interface Inc. Files 8-K for Q3 2026 Earnings Release

Interface, Inc. filed a Form 8-K with the SEC on November 6, 2026, reporting its financial results for the third quarter of 2026 and furnishing an updated investor slide presentation.

Shwetambri Chauhan | 06 November 2026

Atmus Filtration Launches $300M Share Repurchase Program

Atmus Filtration Technologies Inc. filed a Form 8-K with the SEC on November 6, 2026, disclosing third-quarter 2026 financial results and the approval of a new $300 million stock repurchase program, effective immediately.

Anjali Anand | 06 November 2026

Perspective Therapeutics Discloses VMT-α-NET Phase 1/2a Data at NANETS 2026

Perspective Therapeutics, Inc. filed a Form 8-K on November 6, 2026, disclosing that on November 5, 2026, the company issued a press release and posted presentations announcing incremental clinical trial data for its VMT-α-NET program at the NANETS 2026 Multidisciplinary NET Medical Symposium.

Aakashdeep | 06 November 2026

Precision BioSciences Prices $116.5M Offering at $7.75 Per Share

Precision BioSciences, Inc. filed a Form 8-K on November 6, 2026, disclosing the pricing and terms of a public offering of common stock and pre-funded warrants entered into on November 5, 2026, with estimated net proceeds of approximately $116.5 million.

Shwetambri Chauhan | 06 November 2026

HSBC Raises Tender Offer Cap to $1.5B for 6% Perpetual Notes

HSBC Holdings plc filed a Form 6-K on 6 November 2026 announcing an increase to the maximum tender amount of its cash tender offer for its outstanding 6.000% Perpetual Subordinated Contingent Convertible Securities, raising the cap from $1,000,000,000 to $1,500,000,000.

Manish Choudhary | 06 November 2026

Diageo 2026 AGM: All 25 Resolutions Passed

Diageo plc filed a Form 6-K with the SEC on 6 November 2026 reporting that all 25 resolutions put to shareholders at its Annual General Meeting held on 5 November 2026 were passed.

Aakashdeep | 06 November 2026

Essent Group Q3 2026 Financial Results Announced

Essent Group Ltd. filed a Form 8-K with the SEC on November 6, 2026, disclosing the issuance of a press release announcing its financial results for the quarter ended September 30, 2026.

Aditi Sarkar | 06 November 2026

Gal Nir Klein Buys 19,940 Silynxcom Shares Over Two Days

Silynxcom Ltd. Director and VP Marketing and Israel Sales Gal Nir Klein filed a Form 4 on November 6, 2026, disclosing open-market purchases of ordinary shares on November 3 and November 4, 2026.

Aakashdeep | 06 November 2026

Director Epstein Buys 15,000 AgomAb Shares at $6.81-$6.98

Director David R. Epstein filed a Form 4 with the SEC on November 6, 2026, disclosing three open-market purchases of AgomAb Therapeutics NV common shares made on November 5, 2026, totaling 15,000 shares acquired at prices ranging from $6.81 to $6.98 per share.

Vinay Lochav | 06 November 2026

Fowler Sells 1,575 StoneX Shares at $56.87 on Nov 5

Director John Moore Fowler filed a Form 4 with the SEC on November 5, 2026, disclosing the sale of 1,575 shares of StoneX Group Inc. common stock under a Rule 10b5-1 plan.

Manish Choudhary | 06 November 2026
Support

Hi! How can we help you today?

Loading…